Cartesian Growth Co. II (NASDAQ:RENE - Get Free Report) was the target of a significant growth in short interest during the month of March. As of March 15th, there was short interest totalling 1,700 shares, a growth of 142.9% from the February 29th total of 700 shares. Approximately 0.0% of the company's shares are sold short. Based on an average daily trading volume, of 48,300 shares, the short-interest ratio is currently 0.0 days.
Cartesian Growth Co. II Price Performance
NASDAQ RENE traded down $0.01 during mid-day trading on Thursday, reaching $11.11. 11,219 shares of the stock were exchanged, compared to its average volume of 64,194. Cartesian Growth Co. II has a one year low of $10.47 and a one year high of $11.92. The stock has a 50 day simple moving average of $11.06 and a 200-day simple moving average of $10.95.
Institutional Investors Weigh In On Cartesian Growth Co. II
Hedge funds and other institutional investors have recently bought and sold shares of the stock. Evercore Wealth Management LLC bought a new stake in Cartesian Growth Co. II in the fourth quarter valued at $120,000. Captrust Financial Advisors bought a new stake in shares of Cartesian Growth Co. II during the third quarter worth about $194,000. Condor Capital Management bought a new stake in shares of Cartesian Growth Co. II during the fourth quarter worth about $201,000. XTX Topco Ltd bought a new stake in shares of Cartesian Growth Co. II during the second quarter worth about $227,000. Finally, Barclays PLC bought a new stake in shares of Cartesian Growth Co. II during the second quarter worth about $232,000. 58.96% of the stock is owned by institutional investors.
About Cartesian Growth Co. II
(
Get Free Report)
Cartesian Growth Corporation II does not have significant operations. It focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or other similar business combination with one or more businesses or entities. Cartesian Growth Corporation II was incorporated in 2021 and is based in New York, New York.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Cartesian Growth Co. II, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cartesian Growth Co. II wasn't on the list.
While Cartesian Growth Co. II currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
